FATE-NK100 as Monotherapy and in Combination with Monocl

Project: Research project

Project Details

Description

FATE-NK100 as Monotherapy and in Combination with Monoclonal Antibody in Subjects with Advanced Solid Tumors
StatusActive
Effective start/end date8/1/172/28/22

Funding

  • Fate Therapeutics

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.